Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies

Rohan Garje, Miami Cancer Institute
Bruno Bastos, Miami Cancer Institute

Abstract

This paper has been withdrawn.